| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| 2018-01-01 | N/A | Level Brands acquisition of cbdMD | U.S. | View |
This document is a page from a Cowen Collaborative Insights equity research report dated February 25, 2019. It analyzes several companies in the cannabis and tobacco sectors, including GTI, Khiron Life Sciences, Level Brands, Tilray, and Turning Point Brands, providing revenue figures, stock ratings, and acquisition details. The document bears a House Oversight Committee Bates stamp, suggesting it was included in document production for a congressional investigation, likely related to financial institutions, though the page itself contains no direct references to Jeffrey Epstein.
This document is page 46 of a market research report produced by Cowen Collaborative Insights on February 25, 2019. It analyzes the pricing segments of CBD body lotions and bath bombs, listing various brands like Mary's Nutritionals and Lord Jones. While the content is purely financial market analysis, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024862', indicating it was part of a document production for a House Oversight Committee investigation (likely related to financial records subpoenaed in the Epstein/Deutsche Bank probe), though the page itself contains no direct references to Epstein.
This document is page 34 of a Cowen 'Collaborative Insights' market research report dated February 25, 2019. It analyzes the packaging and pricing of CBD gummy products from four different companies: CV Sciences, Green Roads, Highline Wellness, and cbdMD. The document bears a 'HOUSE_OVERSIGHT_024850' Bates stamp, indicating it was part of a document production to the House Oversight Committee, though the content appears to be standard equity research unrelated to criminal activity.
This document is page 31 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019. It analyzes the pricing segments of various CBD capsule brands and presents demographic data (gender, age, income) regarding CBD capsule usage based on a January 2019 survey. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the House Oversight Committee, likely as part of a larger cache of financial or corporate records.
This document is page 26 of a market research report titled 'Cowen Collaborative Insights' dated February 25, 2019. It analyzes the CBD and Hemp industry through the lens of Instagram metrics (followers, posts, likes) for January 2019, comparing emerging brands like CBDFX and Lord Jones against established public companies. While the document bears a 'HOUSE_OVERSIGHT_024842' stamp, suggesting it was part of a document production for a congressional investigation (potentially related to financial probes involving Epstein or Deutsche Bank), the content itself is strictly commercial market analysis with no direct mention of Jeffrey Epstein.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity